National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

HARDBACK
price:$47.95
add to cart

Rights & Permissions

topleft topright

Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program (2005)
Board on Health Sciences Policy (HSP)

Citation Manager

. "Appendix E: A Cost-Benefit Analysis of Increasing Cord Blood Inventory Levels." Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program. Washington, DC: The National Academies Press, 2005.

Please select a format:

BibTeX EndNote RefMan


Page
235
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Cord Blood: Establishing a National Hematopoietic Stem Cell Bank Program

TABLE E-6 Cost Estimates by Inventory Level

 

Cord Inventory

 

50,000

100,000

150,000

200,000

300,000

Cord blood transplants

617

643

655

662

670

Annual cord collection (U)

6,234

11,287

16,310

21,324

31,340

Costs (millions)

Annual bank costs (C)

$10

$17

$25

$32

$47

Direct treatment costs (cTN)

$136

$142

$144

$146

$147

Start-up costs (C0)

$0

$100

$200

$300

$500

Total costs (TC)

$146

$162

$175

$187

$210

Break-even per cord fee (f)

$15,336

$31,107

$46,613

$62,014

$92,675

closely matches what public banks currently charge for a transplanted unit. If a national cord bank maintained an inventory of 150,000 units, the break-even fee could easily triple. Total costs range from $146 million for an inventory of 50,000 units to $210 million for an inventory of 300,000 units. Direct transplant costs account for at least 70 percent of total costs in all of the inventory scenarios.

INCREMENTAL COST-EFFECTIVENESS

Table E-7 displays the incremental cost per life year gained for each inventory level and scenario. For example, under scenario 1, an increase in the inventory from 200,000 to 300,000 units is associated with an additional cost of $23 million and a gain of 212 life years. The incremental cost per life year gained is $106,948 = ($23 million ÷ 212). The difference between scenarios 1 and 2 reflects the fact that in scenario 1 much of the gain in life years from expanding inventory is due to a shift toward better-quality cord blood matches among transplanted patients, rather than a greater absolute number of transplants. Failing to take account of how survival rates vary by match level ignores the survival gains from this first effect.

EQUITY

Equity between racial groups is an important motivation behind the establishment of a national cord bank. We examine the impact of increasing cord inventory on equity by comparing match probabilities and life years gained per patient between African Americans and Caucasians. For

Page
235